|
|
|
| Progress on the Mendelian randomization studies of polyunsaturated fatty acids and diseases |
| HUANG Huijun, CHEN Gang, QIAN Yu, ZHANG Lingzhi, XU Lanjing, YE Ding, MAO Yingying
|
| Department of Epidemiology,School of Basic Medical Sciences & Public Health,Zhejiang Chinese Medical University, Hangzhou,Zhejiang 310053,China |
|
|
|
|
Abstract There are limitations in observational epidemiological studies when exploring the relationships between polyunsaturated fatty acids（PUFAs）and risk of diseases. Recent years have seen Mendelian randomization（MR）being widely employed in etiology research,since it can avoid bias caused by confounding factors and reverse causality in observational epidemiological studies. With the development of PUFAs related genome-wide association studies,MR study design and statistical Methods,MR studies have been conducted to investigate the relationships of PUFAs and risk of diseases including cancer and autoimmune disease. We systematically reviewed the published literature of MR studies on the association between PUFAs and risk of diseases,so as to discuss the underlying advantages and disadvantages of MR studies and to provide clues for further understanding the role of PUFAs in health and disease.
|
|
Received: 23 September 2019
Revised: 20 October 2019
Published: 27 February 2020
|
|
|
|
|
|
[1] MARKLUND M,WU J H Y,IMAMURA F,et al.Biomarkers of dietary omega-6 fatty acids and incident cardiovascular disease and mortality[J].Circulation,2019,139(21):2422-2436.
[2] LIYANAGE U E,ONG J S,AN J,et al.Mendelian randomization study for genetically predicted polyunsaturated fatty acids levels on overall cancer risk and mortality[J].Cancer Epidemiol Biomarkers Prev,2019,28(6):1015-1023.
[3] YAN B,HUANG J,ZHANG C,et al.Serum metabolomic profiling in patients with systemic lupus erythematosus by GC/MS[J].Mod Rheumatol,2016,26(6):914-922.
[4] BURGESS S,DANIEL R M,BUTTERWORTH A S,et al.Network Mendelian randomization:using genetic variants as instrumental variables to investigate mediation in causal pathways[J].Int J Epidemiol,2015,44(2):484-495.
[5] ZHENG J,BAIRD D,BORGES M C,et al.Recent developments in Mendelian randomization studies[J].Curr Epidemiol Rep,2017,4(4):330-345.
[6] 王萍,张银波,江木兰.多不饱和脂肪酸的研究进展[J].中国油脂,2008,33(12):42-46.
[7] KETTUNEN J,DEMIRKAN A,WRTZ P,et al.Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA[J].Nat Commun,2016,7:11122.
[8] LEMAITRE R N,TANAKA T,TANG W,et al.Genetic loci associated with plasma phospholipid n-3 fatty acids:a meta-analysis of genome-wide association studies from the CHARGE Consortium[J].PLoS Genet,2011,7(7):e1002193.
[9] GUAN W,STEFFEN B T,LEMAITRE R N,et al.Genome-wide association study of plasma N6 polyunsaturated fatty acids within the cohorts for heart and aging research in genomic epidemiology consortium[J].Circ Cardiovasc Genet,2014,7(3):321-331.
[10] KROGER J,SCHULZE M B.Recent insights into the relation of Delta5 desaturase and Delta6 desaturase activity to the development of type 2 diabetes[J].Curr Opin Lipidol,2012,23(1):4-10.
[11] WANG C,QIN N,ZHU M,et al.Metabolome-wide association study identified the association between a circulating polyunsaturated fatty acids variant rs174548 and lung cancer[J].Carcinogenesis,2017,38(11):1147-1154.
[12] LIU J,ZHOU H,ZHANG Y,et al.Docosapentaenoic acid and lung cancer risk:A Mendelian randomization study[J].Cancer Med,2019,8(4):1817-1825.
[13] MAY-WILSON S,SUD A,LAW P J,et al.Pro-inflammatory fatty acid profile and colorectal cancer risk:a Mendelian randomisation analysis[J].Eur J Cancer,2017,84:228-238.
[14] ISOM C A,SHRUBSOLE M J,CAI Q,et al.Arachidonic acid and colorectal adenoma risk:a Mendelian randomization study[J].Clin Epidemiol,2019,11:17-22.
[15] KHANKARI N K,MURFF H J,ZENG C,et al.Polyunsaturated fatty acids and prostate cancer risk:a Mendelian randomisation analysis from the PRACTICAL consortium[J].Br J Cancer,2016,115(5):624-631.
[16] ZHAO J V,SCHOOLING C M.Role of linoleic acid in autoimmune disorders:a Mendelian randomisation study[J].Ann Rheum Dis,2019,78(5):711-713.
[17] LEE Y H.Role of linoleic acid in autoimmune disorders: a Mendelian randomisation study[J/OL].[2019-10-20].https://www.ncbi.nlm.nih.gov/pubmed/30563870.
[18] ZHAO J V,SCHOOLING C M.Effect of linoleic acid on ischemic heart disease and its risk factors:a Mendelian randomization study[J].BMC Med,2019,17(1):61.
[19] ZHAO J V,SCHOOLING C M.The role of linoleic acid in asthma and inflammatory markers:a Mendelian randomization study[J].Am J Clin Nutr,2019,110(3):685-690.
[20] SALLIS H,STEER C,PATERNOSTER L,et al.Perinatal depression and omega-3 fatty acids:a Mendelian randomisation study[J].J Affect Disord,2014,166:124-131.
[21] DAVEY SMITH G,HEMANI G.Mendelian randomization:genetic anchors for causal inference in epidemiological studies[J].Hum Mol Genet,2014,23(R1):R89-98.
[22] BOWDEN J,DAVEY SMITH G,BURGESS S.Mendelian randomization with invalid instruments:effect estimation and bias detection through Egger regression[J].Int J Epidemiol,2015,44(2):512-525.
[23] VERBANCK M,CHEN C Y,NEALE B,et al.Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases[J].Nat Genet,2018,50(5):693-698.
[24] BURGESS S,THOMPSON S G.Multivariable Mendelian randomization:the use of pleiotropic genetic variants to estimate causal effects[J].Am J Epidemiol,2015,181(4):251-260. |
|
|
|
